fingolimod
Ligand Summary
A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
UNII: 3QN8BYN5QF
PubChem: 57516011
PubChem: 107970
Guide to Pharmacology: 2407
ChEMBL: CHEMBL544665
ChEMBL: CHEMBL314854
DrugCentral: 4167
LyCHI: 7TJCA8256R3B
Target Activities
13 Activities
Items per page:
10
1 – 10 of 13
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | AGONIST | |||||